Back to Search Start Over

Reduced Severity in Patients With HIV-Associated Disseminated Histoplasmosis With Deep Lymphadenopathies: A Trench War Remains Within the Lymph Nodes?

Authors :
Nacher M
Alsibai KD
Adenis A
Blaizot R
Abboud P
Demar M
Djossou F
Epelboin L
Misslin C
Ntab B
Valdes A
CouppiƩ P
Source :
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Feb 08; Vol. 10, pp. 598701. Date of Electronic Publication: 2021 Feb 08 (Print Publication: 2020).
Publication Year :
2021

Abstract

Background: Disseminated histoplasmosis is a major killer of patients with advanced HIV. It is proteiform and often hard to diagnose in the absence of diagnostic tests. We aimed to describe disseminated histoplasmosis with lymphadenopathies in French Guiana and to compare survival and severity of those patients to patients without lymphadenopathies.<br />Methods: A retrospective cohort study was performed on data records collected between January 1, 1981 and October 1, 2014.<br />Results: Among 349 cases of disseminated histoplasmosis 168 (48.3%) had superficial lymphadenopathies and 133(38.1%) had deep lymphadenopathies. The median LDH concentration, ferritin concentration, TGO concentration, and WHO performance status were lower among patients with deep lymphadenopathies than those without deep lymphadenopathies. There was a significant decrease in the risk of early death (<1 month) among those with deep lymphadenopathies relative to those without (OR=0.26 (95%CI=0.10-0.60), P=0.0006) and in the overall risk of death (OR=0.33 (95%CI=0.20-0.55), P<0.0001). These associations remained strongly significant after adjusting for time period, CD4 counts, age, delay between beginning of symptoms and hospital admission, antifungal and antiretroviral treatment.<br />Conclusions: The present data show that in patients with advanced HIV and disseminated histoplasmosis, the presence of deep lymphadenopathies is associated with fewer markers of severity and a lower risk of death. To our knowledge it is the first study to show this. The presence of deep lymphadenopathies is hypothesized to reflect the patient's partially effective defense against H. capsulatum .<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Nacher, Alsibai, Adenis, Blaizot, Abboud, Demar, Djossou, Epelboin, Misslin, Ntab, Valdes and Couppié.)

Details

Language :
English
ISSN :
2235-2988
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in cellular and infection microbiology
Publication Type :
Academic Journal
Accession number :
33628743
Full Text :
https://doi.org/10.3389/fcimb.2020.598701